Gene · 6239
Papers2,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer. | World J Gastroenterol | 2022 | 36156927 | PubTator, text mining | PubMed |
| Global prevalence, characteristics, and future prospects of IncX3 plasmids: A review. | Front Microbiol | 2022 | 36147856 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition by Synergy between Transforming Growth Factor-β and Growth Factors in Cancer Progression. | Diagnostics (Basel) | 2022 | 36140527 | PubTator, text mining | PubMed |
| Platelets' Nanomechanics and Morphology in Neurodegenerative Pathologies. | Biomedicines | 2022 | 36140340 | PubTator, text mining | PubMed |
| Single-Stranded DNA Binding Proteins and Their Identification Using Machine Learning-Based Approaches. | Biomolecules | 2022 | 36139026 | PubTator, text mining | PubMed |
| Catalytic confinement effects in nanochannels: from biological synthesis to chemical engineering. | Nanoscale Adv | 2022 | 36134369 | PubTator, text mining | PubMed |
| Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy. | Cell Commun Signal | 2022 | 36131281 | PubTator, text mining | PubMed |
| Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. | Nat Commun | 2022 | 36130950 | PubTator, text mining | PubMed |
A 29-MRNA HOST RESPONSE WHOLE-BLOOD SIGNATURE IMPROVES PREDICTION OF 28-DAY MORTALITY AND 7-DAY INTENSIVE CARE UNIT CARE IN ADULTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH SUSPECTED ACUTE INFECTION AND/OR SEPSIS. | Shock | 2022 | 36125356 | PubTator, text mining | PubMed |
| Review of potential medical treatments for middle ear cholesteatoma. | Cell Commun Signal | 2022 | 36123729 | PubTator, text mining | PubMed |
| Tourniquet use following blast-associated complex lower limb injury and traumatic amputation promotes end organ dysfunction and amplified heterotopic ossification formation. | J Orthop Surg Res | 2022 | 36123728 | PubTator, text mining | PubMed |
| Fabrication of a magnetic alginate-silk fibroin hydrogel, containing halloysite nanotubes as a novel nanocomposite for biological and hyperthermia applications. | Sci Rep | 2022 | 36104466 | PubTator, text mining | PubMed |
| 3D multiple immunoimaging using whole male organs in rice. | Sci Rep | 2022 | 36104379 | PubTator, text mining | PubMed |
| Hyperplastic melanocytes with chromosomal aberrations in surrounding skin of subungual melanoma: fluorescence in situ hybridisation analysis using whole-slide digital imaging. | Histopathology | 2022 | 36094779 | PubTator, text mining | PubMed |
| Role of syndecan-4 in breast cancer pathophysiology. | Am J Physiol Cell Physiol | 2022 | 36094435 | PubTator, text mining | PubMed |
| Prediction of anti-inflammatory peptides by a sequence-based stacking ensemble model named AIPStack. | iScience | 2022 | 36093066 | PubTator, text mining | PubMed |
| Determinants of maternal near-miss among women admitted to public hospitals in North Shewa Zone, Ethiopia: A case-control study. | Front Public Health | 2022 | 36091552 | PubTator, text mining | PubMed |
| Circular RNAs regulate parental gene expression: A new direction for molecular oncology research. | Front Oncol | 2022 | 36091137 | PubTator, text mining | PubMed |
| The in vivo Interaction Landscape of Histones H3.1 and H3.3. | Mol Cell Proteomics | 2022 | 36089195 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas-A Prospective Cohort Study. | J Clin Med | 2022 | 36079127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6239/papers?page=20